RealMan

RealMan Intelligent Technology stands as China’s first company to achieve large-scale commercialization of humanoid robot arms, with complete in-house development of all four core components: controllers, drivers, motors, and reducers. Founded in 2018 and headquartered in Beijing’s Shijingshan District, the company has established manufacturing facilities in Changzhou, Jiangsu Province, with annual production capacity exceeding 5,000 units.

Company Overview

The company emerged from China’s early robotics research community, with core team members bringing over a decade of experience in foundational robot technology development. RealMan develops proprietary technology across the robotics value chain, creating ultra-lightweight humanoid robot arms; the company reports payload-to-weight ratios reaching 1:1.2.

As a National High-Tech Enterprise, RealMan maintains strategic partnerships with leading academic institutions including Beihang University, Beijing Institute of Technology, and China Agricultural University. The company ranked 44th in the 2024 China Technology Robot Enterprise Top 50 list. By 2025, RealMan had accumulated 87 patents and 10 software copyrights.

In October 2025, RealMan signed an agreement with Wujin National High-Tech Zone to establish an embodied intelligence R&D and manufacturing base with total investment of RMB 300 million, targeting annual production of 300,000 core component sets.

Core Products

Ultra-Lightweight Humanoid Robot Arms

The flagship product line features robot arms with self-weight of only 6kg (7.2kg including integrated controller), rated payload of 5kg, and peak load capacity of 9kg. The embedded homogeneous multi-core control system eliminates the need for traditional external control cabinets.

Product series include:

• RM Series: Standard industrial robot arms
• ECO Series: Cost-effective application solutions (ECO65, ECO62, ECO63)
• GEN Series: Consumer-grade robot arms, with GEN72 priced around $1,000 for 2kg payload applications
• RML Series: Compound robots with mobility

Healthcare & Physiotherapy Solutions

RealMan’s AI Physiotherapy Robot integrates Traditional Chinese Medicine principles with advanced robotics, utilizing infrared thermal imaging for trajectory generation combined with force-controlled manipulation to replicate master-level massage techniques. Applications span massage, physical therapy, and moxibustion across rehabilitation centers, healthcare institutions, and elderly care facilities.

Embodied Intelligence Platforms

In August 2025, RealMan launched the RealBOT open-source embodied intelligence platform at the World Robot Conference. The dual-arm teleoperation system, trained through imitation learning algorithms, achieves 90% task execution success rate after just 50 demonstration sessions.

Technology & Innovation

RealMan’s technical differentiation centers on complete vertical integration of core components:

• Proprietary Reducers: Harmonic reducers with minimal backlash and 0.01° output accuracy
• Integrated Actuators: WHJ series joints achieving maximum torque density of 200 N·m/kg and peak torque output of 360 Nm in 88mm diameter packages
• Embedded Control Systems: All motion control, dynamics processing, safety monitoring, and user interfaces run on integrated low-cost embedded controllers
• Force Control: Current-loop based joint force control enabling collision detection and drag teaching without external torque sensors

The robot arms feature MTBF certification from Shanghai National Robot Testing Center for 30,000-hour continuous operation under rated load.

Market Presence

RealMan products serve diverse verticals including new retail, smart dining, commercial services, healthcare, intelligent inspection, education and research, industrial manufacturing, and aerospace. The company is rapidly expanding internationally, with strong growth in Asia and active engagement with automation integrators and research institutions in North America.

In September 2025, RealMan formed a strategic partnership with Rongqi Health to jointly develop AI physiotherapy robots, supporting the “Hundred Cities, Thousand Stores” strategic plan to deploy AI-powered wellness services nationwide.

Key Milestones

• 2018: Company founded in Beijing
• 2023: Completed Series A+ funding led by Ecovacs, followed by Series A++ round
• 2024: Ranked 44th in China Technology Robot Enterprise Top 50
• 2025: Launched RealBOT embodied intelligence platform; partnered with China Telecom AI and Rongqi Health; established Wujin manufacturing base

Frequently Asked Questions

What makes RealMan robot arms different from other cobots?

RealMan is the only Chinese company with fully proprietary development of all four core components (controller, driver, motor, reducer), achieving ultra-lightweight designs with payload-to-weight ratios of 1:1.2—significantly better than traditional collaborative robots.

Does RealMan offer medical-grade certified products?

RealMan’s healthcare products are positioned as commercial wellness and rehabilitation equipment rather than medical devices, primarily serving wellness clinics, rehabilitation centers, and elderly care facilities. They are not marketed as regulated medical devices requiring NMPA/CE/FDA clearance.

What is RealMan’s pricing range?

Product pricing varies by series. The consumer-grade GEN72 starts around $1,000, while industrial ECO65 models with grippers are available around $12,000. Healthcare and compound robot solutions are priced based on configuration.